Phase 4
Completed N=88
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
Hypotrichosis
Source: ClinicalTrials.gov NCT01448525 ↗
Enrolled (actual)
88
Serious AEs
0.0%
Results posted
May 2013
Primary outcomePrimary: Percentage of Participants Who Are Satisfied or Very Satisfied With Their Eyelashes Overall — 67.4; 7.1 Percentage of participants
Summary
The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Who Are Satisfied or Very Satisfied With Their Eyelashes Overall |
67.4; 7.1 | — |
| SECONDARY Percentage of Participants With at Least a 1-Grade Increase in the Global Eyelash Assessment (GEA) Score |
72.1; 19.0 | — |
Eligibility Criteria
Inclusion Criteria
- Have inadequate eyelashes
- Never used prescription eyelash growth products
Exclusion Criteria
- No visible eyelashes
- Permanent eyeliner or eyelash implants
- Semi-permanent eyelash tint, dye, or extensions within 3 months
- Over-the-counter eyelash growth products within 6 months
- Any disease, infection or abnormality of the eye or area around the eye
- Eye surgery within 3 months, or the anticipated need for eye surgery during the study
- Unable or unwilling to keep contact lenses out during drug application and for 30 minutes after application
Data sourced from ClinicalTrials.gov (NCT01448525). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.